Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Diabetes Mellitus, Type 1Pregnancy in Diabetes

Interventions

DRUG

Metformin

Participants randomized to metformin will receive metformin in addition to standard treatment of diabetes during pregnancy

Trial Locations (1)

Magee Womens Hospital of UPMC, Pittsburgh

All Listed Sponsors

lead

Maisa N. Feghali, MD

OTHER